We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » LEX PHARMACEUTICAL WARNED FOR cGMP VIOLATIONS
LEX PHARMACEUTICAL WARNED FOR cGMP VIOLATIONS
January 19, 2005
Drugmaker Lex Pharmaceutical has been issued a warning letter following an FDA inspection that revealed a slew of manufacturing violations at the company’s Medley, Fla., plant.